Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 523 clinical trials
Study Looking at Biomarkers in Ovarian Cancer

This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the

ovarian cancer
cancer
  • 20 views
  • 20 Apr, 2021
  • 5 locations
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare LOXO-305 to other drugs that work in a similar way that have

measurable disease
acalabrutinib
cancer
neutrophil count
ibrutinib
  • 0 views
  • 18 Jun, 2021
  • 64 locations
A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH

hematological malignancies that harbor IDH mutations.

  • 0 views
  • 26 Apr, 2021
  • 3 locations
Allogeneic Hematopoietic Stem Cell Transplantation

To assess the engraftment of hematopoietic stem cells following reduced-intensity conditioning in children presenting with solid tumors or hematological malignancy by evaluating post

cell transplantation
fludarabine
cancer
solid tumor
hematologic malignancy
  • 18 views
  • 07 Nov, 2020
  • 1 location
Intrabone Cord Blood Transplantation

The purpose of this study is to evaluate the viability of intrabone administration of umbilical cord blood as allogenic transplantation for the treatment of hematologic malignancies.

umbilical cord blood transplantation
cancer
  • 20 views
  • 07 Nov, 2020
  • 1 location
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

A study of pharmacokinetics of daily intravenous busulfan

cell transplantation
fludarabine
busulfan
  • 38 views
  • 07 Nov, 2020
  • 1 location
Extracorporal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allowed it: 2 ECP per week the first 2 weeks, and 1 ECP per week during 1 month. Total = 8 ECP …

myeloablative conditioning
cancer
allogeneic transplantation
  • 16 views
  • 07 Nov, 2020
  • 1 location
  • 0 views
  • 15 Feb, 2021
  • 1 location
Evolution of Thromboelastography During Tranexamic Acid Treatment

Patients with hematological malignancies are at increased risk of bleeding, especially during intensive chemotherapy. The aim of this study is to compare by thromboelastography changes during

  • 0 views
  • 28 Jan, 2021
  • 2 locations
Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant

The haematological neoplasia relapse is the cause of higher mortality after allogeneic stem cell transplantation (HSCT). When transplantation fails the most common therapeutic strategy is to increase the antitumor activity of the donor's immune system through the infusion of donor Lymphocytes (DLI). The use of DLI may limit the relapse, …

  • 0 views
  • 22 Jan, 2021
  • 1 location